Alphamab Oncology (stock code: 9966.HK) today announced that the first patient has been dosed in a phase III clinical study (JSKN016-301) evaluating JSKN016, a novel TROP2/HER3 bispecific ...
Abstract: A semi-analytical method is presented in this article for evaluating the magnetic properties of soft magnetic composites (SMCs), and the quantitative structure-activity relationship between ...
Abstract: In this paper, we propose a system that verifies the authenticity of users based on the manner in which they operate a computer mouse. To begin with, we introduce a recurrence plot ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results